Shalby Ltd. · NSE:SHALBY
Shalby — Q3 FY2019 Earnings Presentation
30 slides from Shalby's earnings presentation, Jan 29, 2019
Slide 1: Exchange filing cover letter for Q3 FY19 investor presentation
January 29, 2019 Shalby/SE/2017‐18/92 The Listing Department Corporate Service Department National Stock Exchange of India Ltd BSE Limited Exchange Plaza, Plot no. C/1, G Block, 25th Floor, Phiroze Jeejeebhoy Towers, Bandra‐Kurla Complex, Bandra (E), Dalal Street, Mumbai 400 051. Mumbai 400 001. Scr
Slide 2: Investor Presentation Q3 FY 19
Investor Presentation Q3 FY 19
Slide 3: Important Disclosure
Important Disclosure No representation or warranty, express or implied is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of such information or opinions contained herein. The information contained in this presentation is only current as of its da
Slide 4: Because passion drives perfection
…because passion drives perfection… …and perfection drives performance “ 3
Slide 5: Current Scale of Operations
Current Scale of Operations 11 Hospitals 55% Operating bed to total bed capacity 2,012* Total Bed Capacity 45% Bed Occupancy (based on census beds) 1,102** Operational beds 31% 11 year CAGR Revenue 887 Census Beds 40% 11 year CAGR EBITDA 165 Non Census Beds 404 Doctors & 3,000+ Support Staff Double-
Slide 6: Decadal track record
Decadal track record 5
Slide 7: Best in class financials
Best in class financials Revenue EBITDA Revenue (in Mn) Growth (%) 3,555 EBITDA (in Mn) Margin (%) 3,923 26% 25% 25% 925 3,305 24% 20% 21% 20% 739 149% 37% 2,927 16% 14% 14% 778 55% 2,6102,776 11% 660 687 24% 38% 29% 579 21% 26% 2,307 19% 482 13% 13% 439 1,685 1,332 6% 5% 1,030 262 745 482 77 107 14
Slide 8: Best in class economic returns
Best in class economic returns RoCE% RoE% Capital Employed (Rs in Mn) RoCE(%) Net Worth (Rs in Mn) RoE(%) 8,553 7,615 88% 66% 51% 28% 31% 26% 26% 36% 17% 15% 20% 20% 22% 9% 13% 11% 15% 14% 13% 10% 6% 5,488 2% 4,153 2,544 2,508 1,817 1,814 2,109 1,487 852 1,207 844 1,096 239 314 203 259 345 481 181 1
Slide 9: IP and OP Count (Yearly Trend)
IP and OP Count (Yearly Trend) IP Count OP Count 219,057 40,669 222,970 32,967 166,519 125,981 152,921 24,704 128,821 20,528 110,919 15,348 16,609 17,147 55,143 6,983 8,660 9,758 33,285 43,409 5,244 2,413 7,632 19,295 8
Slide 10: IP and OP Count (Quarterly Trend)
IP and OP Count (Quarterly Trend) IP Count OP Count 14,761 13,642 76,794 71,738 12,266 70,525 64,189 9,998 55,554 55,271 8,788 47,956 7,923 42,81944,050 6,142 6,871 5,873 5,818 6,258 37,59042,060 9
Slide 11: Surgeries Count (Yearly Trend)
Surgeries Count (Yearly Trend) Surgeries Count: Arthroplasty vs Others 9,059 6,280 7,399 6,361 8,463 5,586 3,827 2,628 2,014 371 8,006 7,816 8,495 6,856 7,330 6,552 154 5,166 6,019 66 3,576 4,442 1,900 2,596 FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 9M FY19 Arthroplasty Others 10
Slide 12: Surgeries Count (Yearly Trend)
Surgeries Count (Yearly Trend) Arthroplasty Vs Others 3% 6% 9% 31% 34% 39% 45% 44% 46% 49% 52% 56% 97% 94% 91% 69% 66% 61% 55% 56% 54% 51% 48% 44% FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 9M FY19 Arthroplasty Others 11
Slide 13: Surgeries Count (Quarterly Trend)
Surgeries Count (Quarterly Trend) Surgeries - Arthroplasty vs Others 3,155 2,330 2,575 2,689 1,932 2,041 2619 1,870 1,824 2,113 1,773 2,215 1,990 2,139 2,289 2,227 2,325 2,208 2,019 1,874 1,737 1,840 Q1FY17 Q2FY17 Q3FY17 Q4FY17 Q1FY18 Q2FY18 Q3FY18 Q4FY18 Q1FY19 Q2FY19 Q3FY19 Arthroplasty Others 12
Slide 14: Surgeries Count (Quarterly Trend)
Surgeries Count (Quarterly Trend) Arthroplasty Vs Others 47% 50% 51% 48% 49% 50% 53% 54% 58% 55% 56% 53% 50% 49% 52% 51% 50% 47% 46% 42% 45% 44% Arthroplasty Others 13
Slide 15: Performance Q3FY19
~— @ > Performance Q3FY19
Slide 16: Key Achievements of the Quarter
Key Achievements of the Quarter Successfully Awarded Awarded best Medical Value Travel carried out Specialist Hospital “Medical Mohali unit surgery on 5 Award 2018 in Tourism in successfully “Orthopaedics – month old Gujarat broken even Joint Replacement” suffering from instituted by Award” at EBITD
Slide 17: Performance Synopsis
Performance Synopsis (INR in million) Particulars Quarter Ended % of Revenue Quarter Ended % of Revenue Growth 31/12/2018 31/12/2017 Total Revenue 1,151.1 1,013.1 14% EBITDA 213.3 19% 250.8 25% -15% Bed Capacity (Nos.) 2012 2012 0% Operational Beds (Nos.) 1,102 951 16% Average Length of Stay(Days) 2
Slide 18: Financial Highlights Q3FY19 Standalone
Financial Highlights Q3FY19 Standalone (INR in million) Quarter Ended Quarter Ended Particulars 31/12/2018 % of Revenue 31/12/2017 % of Revenue Growth Revenue from Operations 1131.4 966.6 17.1% Other Income 19.7 46.5 -57.7% Total Income 1151.1 1013.1 13.6% Expenses Materials & Consumables 298.5 25.9
Slide 19: Financials Parameters
Financials Parameters (INR in million) Total Revenue EBITDA PAT 128.9 1,151.1 250.8 1,013.1 213.3 104.9 Q3 FY18 Q3 FY19 Q3 FY18 Q3 FY19 Q3 FY18 Q3 FY19 • Total Revenue has increased by 13.6% on Year on Year basis • EBITDA for Q3 FY 19 has decreased by 14.9% compared to Q3 FY 18 as Doctor cost has in
Slide 20: ARPOB and ALOS
ARPOB and ALOS 31,517 30,760 3.75 2.67 Q3 FY18 Q3 FY19 ARPOB (in Rs / day) ALOS (Days) • Change in ALOS is a result of increase in operational excellence as a continuous process as well as increased multi-specialty focus including specialties like Oncology, Nephrology, Cardiac Sciences etc. which ha
Slide 21: Revenue Mix Q3FY19
Revenue Mix Q3FY19 Specialty Mix Payer Profile 12% 5% 4% 15% 5% 43% 7% 18% 8% 63% 10% 12% Arthroplasty Critical Care & General Medicine Self Pay Corporate Government TPA Corporate Private Cardiac Science Oncology Other Ortho Neurology Nephrology Others 20
Slide 22: Surgery Count and Cost Structure Q3FY19
Surgery Count and Cost Structure Q3FY19 Cost Structure Surgery Count 18% 81% 3% 5% 2% 3% 44% 19% 3% 6% 27% 6% 26% 6% 14% Q3FY19 Total Cost Arthroplasty Orthopaedic Advertising and Promotion General Surgery Nephrology Administrative Expenses Employee Cost Gynecology & IVF Cosmetic & Plastic Surgery O
Slide 23: Bed Count Split
Bed Count Split 2,012 2,012 1,102 951 358 397 Q3 FY18 Q3 FY19 Bed Capacity Operational Occupied 22
Slide 24: Maturity Profile – Q3FY19
Maturity Profile – Q3FY19 Avg. Operational Non- Non-Census Total Bed Maturity Profile Occupied Census Beds Beds Operational Beds Capacity Beds Beds 4 years + (SG; Vijay; 149 325 57 382 212 594 Krishna; Vapi) 2-4 years (Jabalpur, 120 309 52 361 115 476 Indore) < 2 years (Jaipur; Naroda; 128 583 892 2
Slide 25: Maturity Profile – Q3FY19 – with Revenue mix
Maturity Profile – Q3FY19 – with Revenue mix Maturity % of Total Non Arthroplasty ARPOB(Rs) ALOS(Days) EBITDA % Profile Revenue Arthroplasty 4 years + (SG; Vijay; 50% 30% 20% 41,629 3.73 29.7% Krishna; Vapi) 2-4 years (Jabalpur, 4% 18% 22,861 3.38 6.5% Indore) 22% < 2 years 28% (Jaipur; Naroda; Sura
Slide 26: Maturity Profile – Q3 FY19 vs Q3 FY18 – Operational Parameters
Maturity Profile – Q3 FY19 vs Q3 FY18 – Operational Parameters Q3 FY 19 Q3 FY 18 Maturity Profile IP Count OP Count Surgery Count Maturity Profile IP Count OP Count Surgery Count 4 years + 4 years + (SG; Vijay; 3,673 26,955 2,531 (SG; Vijay; 4,006 26,665 3,150 Krishna; Vapi) Krishna; Vapi) 2-4 years
Slide 27: Shareholding Pattern
Shareholding Pattern Shareholding as on 31st December 2018 0.54% 0.31% 0.12% Promoter Individuals 0.91% 0.30% 0.05% 0.02% Resident Individuals 0.94% Foreign Portfolio - Corp 4.24% 5.78% Bodies Corporates Employee Trusts 7.39% Alternative Investment Fund HUF Non Resident Indians Mutual Funds Non Resi
Slide 28: Our Strengths and Differentiators
Our Strengths and Differentiators Strong brand, Increasing focus Experienced global Optimized on Quaternary promoters with leadership in Business Model treatments such hands-on Joint now being as Oncology and involvement Replacement replicated Organ transplants Even after the Strong emphasis Leaders
Slide 29: Detailed Information
Detailed Information For more detailed information please click on the link below: • Q3FY19 result • Q2FY19 result • Q1FY19 result • Monitoring Agency Report for IPO proceeds • FY18 result 28
Slide 30: Thank you
Thank you SHALBY LIMITED Regd Off: Opp. Karnavati Club, S.G. Road, Ahmedabad – 380015, Gujarat, India. Phone: 079 4020 3000 Fax: +91 79 4020 3120 | Website: www.shalby.org | CIN: L85110GJ2004PLC044667 Script code: BSE: 540797 | NSE: SHALBY